Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

China flag China · Delayed Price · Currency is CNY
50.02
-1.12 (-2.19%)
Jun 10, 2026, 3:00 PM CST
Market Cap5.47B +13.4%
Revenue (ttm)1.19B +12.4%
Net Income194.92M +45.2%
EPS1.76 +46.8%
Shares Out 109.28M
PE Ratio28.45
Forward PEn/a
Dividend0.19 (0.37%)
Ex-Dividend Daten/a
Volume1,595,004
Open50.63
Previous Close51.14
Day's Range49.62 - 52.64
52-Week Range44.73 - 86.50
Beta-0.02
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:688621

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and o... [Read more]

Sector Healthcare
Founded 2009
Employees 1,335
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688621
Full Company Profile

Financial Performance

In 2025, SHA:688621's revenue was 1.22 billion, an increase of 13.33% compared to the previous year's 1.08 billion. Earnings were 203.87 million, an increase of 14.91%.

Financial Statements